The launch of the Retatru vial marks a significant advance in the field to body regulation. This innovative therapy combines dual mechanisms – activation of the GLP-1 target and blocking of the DPP-4 enzyme – suggesting a unique technique for addressing excess weight . Early patient results suggest encouraging results in promoting meaningful we